Anlon HealthcareNSE:AHCL 17 Pretax Margin % is 2,838.13% as of Mar. 2026, which is 19286% above its 10-year median of 14.64. GuruFocus rates NSE:AHCL with a GF Score™ of 17/100. The stock has 5 warning signs investors should review. Among 954 Drug Manufacturers companies, Anlon Healthcare ranks better than 99.69% on this metric.
The historical rank and industry rank for Anlon Healthcare's Pretax Margin % or its related term are showing as below:
NSE:AHCL'
s Pretax Margin % Range Over the Past 10 Years
Min: -0.19 Med: 14.64 Max: 1058.18
Current: 1058.18
NSE:AHCL's Pretax Margin % is ranked better than 99.69% of 954
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs NSE:AHCL: 1058.18
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Anlon Healthcare Pretax Margin % Related Terms
Anlon Healthcare Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Anlon Healthcare's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Anlon Healthcare's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anlon Healthcare Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Anlon Healthcare's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Anlon Healthcare's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anlon Healthcare (NSE:AHCL) has a Pretax Margin % of 2,838.13% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Anlon Healthcare and its competitors. This is 19286% above median its historical median of 14.64. According to the industry distribution chart, Anlon Healthcare ranks #3 out of 954 companies in the Drug Manufacturers industry, placing it in the top 0.3%.
Is Anlon Healthcare's Pretax Margin % too high?
Anlon Healthcare's current Pretax Margin % of 2,838.13% is 19286% above median its 10-year median of 14.64. The Drug Manufacturers industry median Pretax Margin % is 7.30. Anlon Healthcare's value of 2,838.13% is 38805.1% above this industry median. Based on the distribution chart, Anlon Healthcare ranks #3 out of 954 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Anlon Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Anlon Healthcare ranks #3 out of 954 companies for Pretax Margin %. This places Anlon Healthcare in the top 0% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.30. Anlon Healthcare's value of 2,838.13% is 38805.1% above this benchmark. While the company's 10-year median is 14.64 vs. the industry median of 7.30, Anlon Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anlon Healthcare's current Pretax Margin % of 2,838.13% is 38805.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Anlon Healthcare and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anlon Healthcare's current Pretax Margin % is 2,838.13%, which is 19286% above median its own 10-year median of 14.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Pretax Margin % of 2,838.13%. The current Pretax Margin % is 2,838.13%, which is 19286% above median its 10-year median of 14.64 and 38805.1% above the Drug Manufacturers industry median of 7.30. Anlon Healthcare's overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Pretax Margin % is 2,838.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
17GF Score
Get the complete analysis for NSE:AHCL
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AHCL has been successfully added to your 
